This pilot study is designed to test the logistics and recruitment of a trial testing the benefit of sodium nitrate in the prevention of contrast-associated kidney injury in a group of patients at high-risk.
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Percent of participants receiving the first dose of blinded study drug within 1-8 hours prior to contrast exposure
Timeframe: Approximately 34 days
Percent of participants completing full course of 4 doses of blinded study drug
Timeframe: Approximately 34 days
Percent of participants with 48-hour basic metabolic panel collected between 36-108 hours of contrast exposure
Timeframe: Approximately 34 days
Percent of participants who had completion of clinical outcome monitoring at 30-day follow-up interview
Timeframe: Approximately 34 days
Percent of participants recruited to the trial for undergoing coronary angiogram
Timeframe: Approximately 34 days
Percent of participants recruited to the trial for undergoing a contrast-enhanced CT scan
Timeframe: Approximately 34 days